{"id":9449,"date":"2022-11-01T08:58:49","date_gmt":"2022-11-01T08:58:49","guid":{"rendered":"https:\/\/staging.grindeks.eu\/?post_type=our_stories&#038;p=9449"},"modified":"2022-11-01T09:00:42","modified_gmt":"2022-11-01T09:00:42","slug":"kirovs-lipmans-vajag-turpinat-iesakto","status":"publish","type":"our_stories","link":"https:\/\/grindeks.com\/lv\/our_stories\/kirovs-lipmans-vajag-turpinat-iesakto\/","title":{"rendered":"Kirovs Lipmans: Vajag turpin\u0101t ies\u0101kto"},"content":{"rendered":"\n<p>Grindeks padomes priek\u0161s\u0113d\u0113t\u0101js Kirovs Lipmans nosauc Grindeks koncerna att\u012bst\u012bbas priorit\u0101tes \u2013 jaunu produktu izstr\u0101de, glob\u0101l\u0101 ekspansija un darba organiz\u0101cijas pilnveide visos koncerna uz\u0146\u0113mumos. Vissvar\u012bg\u0101kais vi\u0146apr\u0101t ir cilv\u0113ki \u2013 darbinieki, kas veido koncerna komandu un pacienti, kas \u0101rst\u0113joties lieto Grindeks z\u0101les.<\/p>\n\n\n<div class=\"wp-block-image is-style-rounded\">\n<figure class=\"alignleft size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/grindeks.com\/wp-content\/uploads\/2022\/11\/image.png\" alt=\"\" class=\"wp-image-9445\" width=\"366\" height=\"431\" title=\"\" srcset=\"https:\/\/grindeks.com\/wp-content\/uploads\/2022\/11\/image.png 724w, https:\/\/grindeks.com\/wp-content\/uploads\/2022\/11\/image-254x300.png 254w, https:\/\/grindeks.com\/wp-content\/uploads\/2022\/11\/image-127x150.png 127w, https:\/\/grindeks.com\/wp-content\/uploads\/2022\/11\/image-480x566.png 480w, https:\/\/grindeks.com\/wp-content\/uploads\/2022\/11\/image-640x755.png 640w, https:\/\/grindeks.com\/wp-content\/uploads\/2022\/11\/image-720x849.png 720w\" sizes=\"(max-width: 366px) 100vw, 366px\" \/><\/figure>\n<\/div>\n\n\n<p><strong>Kas rada liel\u0101kos izaicin\u0101jumus Grindeks darb\u012bb\u0101?<\/strong><strong><\/strong><\/p>\n\n\n\n<p>Farm\u0101cijas industrij\u0101 atbild\u012bga un profesion\u0101la attieksme ir \u012bpa\u0161i svar\u012bga, jo at\u0161\u0137ir\u012bb\u0101 no cit\u0101m jom\u0101m, mums jau \u0161odien ir j\u0101dom\u0101, k\u0101ds b\u016bs m\u016bsu z\u0101\u013cu kl\u0101sts p\u0113c pieciem gadiem un v\u0113l t\u0101l\u0101k\u0101 laika period\u0101. P\u0113tniec\u012bbas un izstr\u0101des proces\u0101 ir j\u0101pier\u0101da z\u0101\u013cu terapeitisk\u0101 ekvivalence, m\u016bsu speci\u0101listiem ir j\u0101prot prognoz\u0113t, k\u0101ds b\u016bs z\u0101\u013cu piepras\u012bjums daudzus gadus uz priek\u0161u. Tas ir \u013coti nopietns darbs un anal\u012bze.<\/p>\n\n\n\n<p>Uzskatu, ka iedzi\u013cin\u0101\u0161an\u0101s jebkura jaut\u0101juma b\u016bt\u012bb\u0101 ir \u013coti noz\u012bm\u012bga. Savulaik uzskat\u012bj\u0101m, ka \u010detri ieviesti produkti gad\u0101 ir \u013coti daudz, bet \u0161obr\u012bd Grindeks raug\u0101s uz att\u012bst\u012bbu daudz pla\u0161\u0101k\u0101s kategorij\u0101s. Jau pag\u0101ju\u0161\u0101 gad\u0101 Grindeks pier\u0101d\u012bja savas prasmes un iesniedza re\u0123istr\u0101cijai 10 medikamentus. Uzskatu, ka tas ir nopietns pav\u0113rsiens uz\u0146\u0113muma att\u012bst\u012bbai. Produktu portfelis, t\u0101tad, ir \u013coti noz\u012bm\u012bgs. T\u0101p\u0113c to es var\u0113tu nosaukt par nopietnu izaicin\u0101jumu.<\/p>\n\n\n\n<p>Raugoties no iedz\u012bvot\u0101ju skaita un pirktsp\u0113jas, pasaul\u0113 ir daudzi perspekt\u012bvi noieta tirgi. M\u016bsu produkcija tiek ra\u017eota p\u0113c pasaules kvalit\u0101tes standartiem, bet cenas zi\u0146\u0101 sp\u0113jam b\u016bt pievilc\u012bgi un konkur\u0113tsp\u0113j\u012bgi, sal\u012bdzinot ar citu z\u0101\u013cu ra\u017eot\u0101ju medikamentiem. Dom\u0101ju, ka Grindeks tirgus strat\u0113\u0123ija, orient\u0113joties uz stabiliem un maks\u0101tsp\u0113j\u012bgiem tirgiem ir pareiza. Vajag turpin\u0101t ies\u0101kto.<\/p>\n\n\n\n<p><strong>K\u0101 J\u016bs sevi raksturotu k\u0101 vad\u012bt\u0101ju?<\/strong><strong><\/strong><\/p>\n\n\n\n<p>Lai k\u013c\u016btu par profesion\u0101lu vad\u012bt\u0101ju, savas darba gaitas uzs\u0101ku jau agr\u0101 jaun\u012bb\u0101, 15 gadu vecum\u0101. L\u012bdztekus darbam es turpin\u0101ju m\u0101c\u012bties. Dz\u012bves apst\u0101k\u013ci tolaik bija smagi, jo m\u0101te slimoja, bet t\u0113vs bija miris. Pats grib\u0113ju str\u0101d\u0101t un k\u013cuvu par atsl\u0113dznieka m\u0101cekli. Pirmo lielo noz\u012bm\u012bgo kolekt\u012bvu es vad\u012bju jau 18 gadus jauns. Komand\u0101 bija 96 darbinieki. Liel\u0101 atbild\u012bba deva milz\u012bgu r\u016bd\u012bjumu visai t\u0101l\u0101kajai dz\u012bvei.<\/p>\n\n\n\n<p>Karjeras ce\u013c\u0101 es izg\u0101ju visus etapus: biju meistars, vec\u0101kais meistars, ceha priek\u0161nieks,<\/p>\n\n\n\n<p>skait\u013co\u0161anas centra vad\u012bt\u0101ja vietnieks\u2026 Esmu ekonomists, beidzu P\u0113terburg\u0101 (toreiz \u013be\u0146ingrad\u0101) instit\u016btu. P\u0113c studij\u0101m str\u0101d\u0101ju uz\u0146\u0113mum\u0101 Krasnaja zarja par ceha priek\u0161nieku, tad mana darba karjera aizveda uz VEF.<\/p>\n\n\n\n<p>Dom\u0101ju, ka ikviens, kas mani paz\u012bst, raksturo k\u0101 m\u0113r\u0137tiec\u012bgu. Manupr\u0101t, vad\u012bt\u0101jam ir j\u0101b\u016bt t\u0101lredz\u012bgam, j\u0101dom\u0101 vair\u0101k nek\u0101 tr\u012bs so\u013cus uz priek\u0161u, jo tu esi komandas virz\u012bt\u0101js un iedvesmot\u0101js. M\u0113r\u0137i vajag uzst\u0101d\u012bt un dar\u012bt visu, lai to sasniegtu. Turkl\u0101t vajag past\u0101v\u012bgi apg\u016bt visu jauno. Esmu \u013coti pras\u012bgs pats pret sevi un attiec\u012bgi ar\u012b pret apk\u0101rt\u0113jiem. Mans moto \u2013 vienm\u0113r var vair\u0101k un vienm\u0113r var lab\u0101k. Tas noz\u012bm\u0113, ka man vienm\u0113r ir m\u0113r\u0137is, uz kuru tiekties.<\/p>\n\n\n\n<p><strong>Vai atceraties savas pirm\u0101s darba dienas Grindek\u0101?<\/strong><strong><\/strong><\/p>\n\n\n\n<p>J\u0101, \u013coti labi atceros to br\u012bdi, kad ieg\u0101d\u0101jos Grindeks akcijas. Lielu lomu par labu \u0161ai izv\u0113lei nosp\u0113l\u0113ja mana sieva Anna Lipmane. Vi\u0146a k\u0101 \u0101rste-neirolo\u0123e iedro\u0161in\u0101ja piev\u0113rsties farm\u0101cijai un z\u0101\u013cu ra\u017eo\u0161anai. Toreiz uz\u0146\u0113muma apgroz\u012bjums bija tikai desmit milj. latu, past\u0101v\u0113ja probl\u0113mas ar darba organiz\u0101ciju un maks\u0101jumiem. Perspekt\u012bvu es saskat\u012bju uzreiz, ta\u010du ar \u013coti b\u016btisku nosac\u012bjumu \u2013 mums ir j\u0101ra\u017eo z\u0101les, kas ir nepiecie\u0161amas pacientiem.<\/p>\n\n\n\n<p>\u0160odien mums ir ar ko lepoties, jo esam Latvijas farm\u0101cijas industrijas flagmanis. Turkl\u0101t m\u0113s konkur\u0113jam ar nopietniem sp\u0113l\u0113t\u0101jiem vis\u0101 pasaul\u0113. Konkurence, protams, k\u013c\u016bst arvien s\u012bv\u0101ka, bet tas ir labs iemesls vairot c\u012b\u0146as sparu un v\u0113lmi b\u016bt elast\u012bg\u0101kiem un sp\u0113j\u012bg\u0101kiem. <\/p>\n\n\n\n<p><strong>Kas ir Grindeks veiksmes atsl\u0113ga? <\/strong><strong><\/strong><\/p>\n\n\n\n<p>Varu dro\u0161i apliecin\u0101t,&nbsp; ka Grindeks uzvaras aug\u013cus nes m\u016bsu produkti. Piem\u0113ram, m\u016bsu Mildron\u0101ts\u00ae ir pla\u0161i paz\u012bstams medikaments, un piepras\u012bjums p\u0113c t\u0101 ir \u013coti augts. Grindeks strat\u0113\u0123iskais virziens uz z\u0101\u013cu pieejam\u012bbas palielin\u0101\u0161anu, pied\u0101v\u0101jot pacientiem vajadz\u012bgus patentbr\u012bvus medikamentus, ir pareiza.<\/p>\n\n\n\n<p>\u013boti svar\u012bgi ir ar\u012b partneri, ar kuriem m\u0113s sadarbojamies. Ieinteres\u0113t\u012bbai un orient\u0101cijai uz rezult\u0101tu j\u0101b\u016bt abpus\u0113jai, neatkar\u012bgi, vai t\u0101 ir z\u0101\u013cu p\u0113tniec\u012bba un izstr\u0101de, iepirkumi vai izplat\u012b\u0161ana. Vienpus\u0113jas biznesa attiec\u012bbas, kuru pamat\u0101 ir tikai materi\u0101li nol\u016bki, nenes nek\u0101dus rezult\u0101tus, par to esmu piln\u012bgi p\u0101rliecin\u0101ts.<\/p>\n\n\n\n<p><strong>Gadu gait\u0101 Grindeks ir k\u013cuvis par starptautisku koncernu. K\u0101du J\u016bs iedom\u0101jaties Grindeks koncerna n\u0101kotni?&nbsp; <\/strong><strong><\/strong><\/p>\n\n\n\n<p>Ja desmit gadus atpaka\u013c nebija p\u0101rliecino\u0161a redz\u0113juma par n\u0101kotni, tad tagad t\u0101 ir skaidra. Vai uz\u0146\u0113mums var past\u0101v\u0113t, sprie\u017eot tikai par \u0161odienu? N\u0113. T\u0101d\u0113\u013c es daudz dom\u0101ju par att\u012bst\u012bbu. Skaidrs, ka, mums augot, rodas nepiecie\u0161am\u012bba p\u0113c pla\u0161\u0101kas infrastrukt\u016bras un jaun\u0101m iek\u0101rt\u0101m, kas palielina ra\u017eo\u0161anas jaudas. <\/p>\n\n\n\n<p>Jo piepras\u012bt\u0101kas b\u016bs m\u016bsu z\u0101les, jo vair\u0101k resursu var\u0113sim atv\u0113l\u0113t invest\u012bcij\u0101m. Past\u0101v\u012bgi invest\u0113jam da\u017e\u0101dos projektos, veicam ieguld\u012bjumus jaun\u0101s iek\u0101rt\u0101s, protams, jaunu produktu izstr\u0101d\u0113. Turpin\u0101s jaun\u0101 Inov\u0101ciju centra projekts, kur\u0101 b\u016btiski papla\u0161in\u0101sim ar\u012b ra\u017eo\u0161anas iesp\u0113jas.<\/p>\n\n\n\n<p>Lai sasniegtu uzst\u0101d\u012btos m\u0113r\u0137us, mums ir j\u0101b\u016bt vienu soli priek\u0161\u0101 glob\u0101lajam farm\u0101cijas tirgum, ta\u010du tas prasa invest\u012bcijas. Es to \u013coti labi apzinos.<\/p>\n\n\n\n<p><strong>Kam Grindeks darb\u012bb\u0101 b\u016btu j\u0101main\u0101s, kam j\u0101att\u012bst\u0101s? <\/strong><strong><\/strong><\/p>\n\n\n\n<p>Mums ir j\u0101att\u012bsta gan m\u0101tes uz\u0146\u0113mums Grindeks, gan meitas uz\u0146\u0113mumi, \u012bpa\u0161i, tie, kas ra\u017eo z\u0101les. J\u0101mekl\u0113 risin\u0101jumi produktivit\u0101tes un efektivit\u0101tes uzlabo\u0161anai. Redzu, ka t\u0101l\u0101k\u0101 n\u0101kotn\u0113 ar\u012b Kalcekam pa\u0161am vajadz\u0113s att\u012bst\u012bt savu injekciju ra\u017eo\u0161anu.<\/p>\n\n\n\n<p><strong>K\u0101das ir J\u016bsu galven\u0101s atzi\u0146as, virzot Grindeku uz pan\u0101kumiem?<\/strong><\/p>\n\n\n\n<p>Grindeks pan\u0101kumi ir m\u016bsu cilv\u0113ku nopelns. Lai cik sp\u0113j\u012bgs ir vad\u012bt\u0101js, bez komandas vi\u0146\u0161 viens neko nevar izdar\u012bt.<\/p>\n\n\n\n<p><strong>Kas Jums Grindek\u0101 sag\u0101d\u0101 visliel\u0101ko gandar\u012bjumu? <\/strong><strong><\/strong><\/p>\n\n\n\n<p>Tie ir m\u016bsu cilv\u0113ki. Prieks b\u016bt uz\u0146\u0113mum\u0101, tikties un kop\u012bgi mekl\u0113t risin\u0101jumus. Tas man sag\u0101d\u0101 milz\u012bgu gandar\u012bjumu. Darbs ir mana sirdslieta. Esmu nep\u0101rtraukti aiz\u0146emts&nbsp; ar Grindeka, Kalceka, HBM Pharma un Tallinas Farmaceitisk\u0101s r\u016bpn\u012bcas jaut\u0101jumiem. Es patiesi priec\u0101jos par m\u016bsu kop\u012bgajiem sasniegumiem, rezult\u0101tiem un pan\u0101kumiem.<\/p>\n\n\n\n<p><strong>K\u0101 izveidot sp\u0113c\u012bgu komandu?<\/strong><\/p>\n\n\n\n<p>Vad\u012bt\u0101jam noteikti ir j\u0101redz, ko sav\u0101 un komandas darb\u0101 var uzlabot. Ar cilv\u0113kiem ir j\u0101run\u0101, un, ja nepiecie\u0161ams, ir j\u0101pam\u0101ca un j\u0101par\u0101da. J\u0101m\u0101k uzklaus\u012bt un ieklaus\u012bties darbinieku padomos, bie\u017ei vien vi\u0146i \u013coti labi par\u0101da un pasaka, ko un k\u0101 var dar\u012bt lab\u0101k.<\/p>\n\n\n\n<p><strong>J\u016bsu nov\u0113l\u0113jums Grindeks komandai. <\/strong><strong><\/strong><\/p>\n\n\n\n<p>M\u016bsu darbinieki ir tie, kas nodro\u0161ina uz\u0146\u0113muma darb\u012bbu. Apzinos, ka pasaules \u0123eopolitiskie notikumi \u0161obr\u012bd sag\u0101d\u0101 raizes piln\u012bgi visiem cilv\u0113kiem. T\u0101p\u0113c mans uzdevums ir par\u016bp\u0113ties, lai m\u016bsu cilv\u0113ki var\u0113tu str\u0101d\u0101t, nelauzot galvu par to, k\u0101 ieg\u0101d\u0101ties sev nepiecie\u0161amo. Ja koncerna r\u0101d\u012bt\u0101ji b\u016bs labi, attiec\u012bgi celsim ar\u012b darba samaksu. Es nov\u0113lu, lai komand\u0101 valda vienot\u012bba, komandas gars un gandar\u012bjums pa paveikto!<\/p>\n\n\n\n<p><strong>Esmu \u013coti pateic\u012bgs visiem pacientiem, vesel\u012bbas apr\u016bpes speci\u0101listiem, klientiem, sadarb\u012bbas partneriem un nov\u0113lu visiem jums ko \u013coti svar\u012bgu \u2013 labu vesel\u012bbu!<\/strong><strong><\/strong><\/p>\n","protected":false},"featured_media":9450,"template":"","class_list":["post-9449","our_stories","type-our_stories","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/our_stories\/9449","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/our_stories"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/our_stories"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/9450"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=9449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}